Flunixin
Drug profile
Also known as: flunixin meglumine, SCH-14714
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Flunixin is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including HDAC6 and DHODH.
- Molecular targets: HDAC6 and DHODH (2 listed in DrugCentral).
- Molecular formula: C14H11F3N2O2; molecular weight 296.25 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histone deacetylase 6 | HDAC6 | unknown | IC50 6.10 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | DHODH | unknown | IC50 5.10 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
Chemical structure
| Molecular formula | C14H11F3N2O2 |
|---|---|
| Molecular weight | 296.25 g/mol |
| CAS number | 38677-85-9 |
| InChIKey | NOOCSNJCXJYGPE-UHFFFAOYSA-N |
| PubChem CID | 38081 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Flunixin work?
Its molecular targets in DrugCentral include HDAC6 and DHODH.
What is the chemical formula of Flunixin?
Flunixin has the molecular formula C14H11F3N2O2 and a molecular weight of 296.25 g/mol.
Browse: all drugs starting with F · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5545 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1617398 — compound record and bioactivity
- PubChem CID 38081 — chemical identifiers
- DrugBank DB11518 — drug record
- FDA UNII 356IB1O400 — substance identity
- DailyMed: FDA labels for Flunixin — current prescribing information (label search)
- UniProt Q9UBN7 (HDAC6) — target protein
- UniProt Q02127 (DHODH) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.